Discover ChipMOS Technologies Inc.'s latest 6-K filing, detailing the upcoming shareholders' meeting and compliance with SEC regulations. Stay informed on key dates and proposals.
Discover key details from Lion Group Holding Ltd.'s Form 6-K, including the extraordinary shareholders' meeting date, filing info, and executive insights.
Discover the key outcomes of NLS Pharmaceutics Ltd.'s extraordinary shareholders' meeting held on January 14, 2025, including approvals and SEC filing insights.
Discover crucial insights from Captivision Inc.'s Form 6-K report on the annual meeting schedule, voting eligibility, and proxy information. Stay informed for shareholder engagement!
Discover key insights from Clearmind Medicine Inc.'s January 2025 Form 6-K, detailing shareholder meeting results, regulatory compliance, and executive updates.
NLS Pharmaceutics Ltd. filed Amendment No. 1 to Form 6-K, correcting the record date for the January 2025 Extraordinary Shareholders’ Meeting. Key SEC compliance details included.
Explore NLS Pharmaceutics Ltd.'s December 2024 Form 6-K report, detailing the upcoming extraordinary shareholder meeting on January 7, 2025, and SEC compliance.